A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors

by | Nov 10, 2025 | Clinical Trials | 0 comments

​ Conditions: Advanced-stage Solid Tumors

Interventions: Drug: JNJ-89862175

Sponsors: Janssen Research & Development, LLC

Recruiting Conditions: Advanced-stage Solid Tumors
Interventions: Drug: JNJ-89862175
Sponsors: Janssen Research & Development, LLC
Recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *